Baxter AG
Penn Pharma
Zuellig

TAKEDA HEALTHCARE PHILIPPINES, INC

Featured products of Takeda
brentuximab vedotin
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX05 - brentuximab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
vedolizumab
Packing/Price
20 mL x 1's
MIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories
ATC Classification
L04AG05 - vedolizumab : Belongs to the class of monoclonal antibodies. Used as immunosuppressants.
leuprorelin acetate
Packing/Price
1's
MIMS Class
Trophic Hormones & Related Synthetic Drugs, Cancer Hormone Therapy
ATC Classification
L02AE02 - leuprorelin : Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.
leuprorelin acetate
Packing/Price
1's
MIMS Class
Trophic Hormones & Related Synthetic Drugs, Cancer Hormone Therapy
ATC Classification
L02AE02 - leuprorelin : Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.
leuprorelin acetate
Packing/Price
1's
MIMS Class
Trophic Hormones & Related Synthetic Drugs, Cancer Hormone Therapy
ATC Classification
L02AE02 - leuprorelin : Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.
ixazomib
Packing/Price
((blister wallet)) 3 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG03 - ixazomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
ixazomib
Packing/Price
((blister wallet)) 3 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG03 - ixazomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Distributor for Baxter AG
anti-inhibitor coagulant complex
Packing/Price
(+ 10 mL solvent) 1's
MIMS Class
Haemostatics
ATC Classification
B02BD03 - factor VIII inhibitor bypassing activity : Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
Distributor for Penn Pharma
brigatinib
Packing/Price
28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED04 - brigatinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
brigatinib
Packing/Price
28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED04 - brigatinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
Distributed by Zuellig
brentuximab vedotin
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX05 - brentuximab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
vedolizumab
Packing/Price
20 mL x 1's
MIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories
ATC Classification
L04AG05 - vedolizumab : Belongs to the class of monoclonal antibodies. Used as immunosuppressants.
leuprorelin acetate
Packing/Price
1's
MIMS Class
Trophic Hormones & Related Synthetic Drugs, Cancer Hormone Therapy
ATC Classification
L02AE02 - leuprorelin : Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.
leuprorelin acetate
Packing/Price
1's
MIMS Class
Trophic Hormones & Related Synthetic Drugs, Cancer Hormone Therapy
ATC Classification
L02AE02 - leuprorelin : Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.
leuprorelin acetate
Packing/Price
1's
MIMS Class
Trophic Hormones & Related Synthetic Drugs, Cancer Hormone Therapy
ATC Classification
L02AE02 - leuprorelin : Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.
ixazomib
Packing/Price
((blister wallet)) 3 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG03 - ixazomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
ixazomib
Packing/Price
((blister wallet)) 3 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG03 - ixazomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.

Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in